← Back to headlines
Novartis Reports New Cosentyx Data in Polymyalgia Rheumatica
Novartis (NVS) has announced new data regarding its drug Cosentyx® in the treatment of Polymyalgia Rheumatica.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Italy Extends Diesel Fuel Tax Cut Through Early September
21m ago
Cisco Abandons Traditional Hardware Restrictions to Pursue AI Infrastructure Boom
31m ago
Executives at Itron and Lyft Sell Significant Company Stock Holdings
33m ago
Senior Official Firmly Rejects External Political Pressure and Influence Attempts
33m ago